MAIA Biotechnology, Inc. (MAIA) Stock Forecast
MAIA analyst forecast
as of October 17, 2026- Analyst consensus
- Strong buy 5.00 / 5 from 1 analysts
- Price target
- $12.00 average of analyst targets
- Upside to target
- +990.9% from the latest close
- Next earnings
- November 6, 2026 EPS estimate $-0.13
- 52-week range
- $0.87 – $2.95
MAIA analyst ratings
1 analystsNumber of analysts at each rating.
MAIA price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
MAIA earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.13 | −$0.13 | −$0.13 | −$0.27 | +51.8% | 1 |
| Current fiscal year (2026) | −$0.54 | −$0.54 | −$0.54 | −$0.73 | +26.5% | 1 |
| Next fiscal year (2027) | $1.11 | −$0.48 | $2.70 | −$0.54 | +305.6% | 2 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
MAIA revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0 | $0 | $0 | 0.0% | 1 |
| Current fiscal year (2026) | $0 | $0 | $0 | 0.0% | 1 |
| Next fiscal year (2027) | $0 | $0 | $0 | 0.0% | 1 |
MAIA EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
MAIA EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.12 | −$0.12 | −$0.12 | −$0.12 | −$0.13 | +8.3% | 0 up · 1 down |
| Current fiscal year (2026) | −$0.52 | −$0.52 | −$0.52 | −$0.52 | −$0.54 | +3.8% | 0 up · 1 down |
| Next fiscal year (2027) | $1.12 | $1.12 | $1.11 | $1.11 | $1.11 | −0.9% | 0 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
MAIA earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; MAIA beat in 7 of 12.
What analysts expect from MAIA
1 analysts cover MAIA Biotechnology; their consensus rating is strong buy (5.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $12.00, 990.9% above the latest close of $1.10. Analysts expect earnings of −$0.54 per share for 2026, +26.5% from a year earlier. For 2027 the average estimate is $1.11 per share. MAIA Biotechnology beat the EPS estimate in 7 of the last 12 quarters.
Related: MAIA income statement, MAIA key metrics, MAIA chart. See the MAIA stock overview for the latest quote and news.
MAIA forecast FAQ
What is MAIA Biotechnology's price target?
The average analyst price target for MAIA Biotechnology is $12.00, 990.9% above the latest close of $1.10.
Is MAIA Biotechnology a buy, hold or sell?
Of 1 analysts covering MAIA Biotechnology, 1 rate it a strong buy, 0 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is MAIA Biotechnology's EPS forecast?
Analysts forecast −$0.54 per share for 2026 (range −$0.54 to −$0.54); for 2027 the estimate is $1.11.
When does MAIA Biotechnology report earnings?
MAIA Biotechnology is expected to report results for the quarter ending September 30, 2026 on November 6, 2026; the EPS estimate is $-0.13.
Does MAIA Biotechnology usually beat earnings estimates?
MAIA Biotechnology reported EPS at or above the analyst estimate in 7 of the last 12 quarters.